Malin-backed US drug firm tipped for €1bn sale

US drug development firm Poseida Therapeutics - of which State-backed investor Malin owns approximately 25% - has been tipped by analysts to fetch €1bn by way of a takeover next year.

Malin-backed US drug firm tipped for €1bn sale

US drug development firm Poseida Therapeutics - of which State-backed investor Malin owns approximately 25% - has been tipped by analysts to fetch €1bn by way of a takeover next year.

San Diego-based Poseida is a clinical trial-stage company working on treatments for various blood-based cancers and solid tumors.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited